首页 > 市场调查报告书 > 食物/饮料

机能性食品

欧洲维生素 K2 市场预测至 2030 年 - 区域分析 - 按产品、剂型、来源和应用

市场调查报告书

商品编码

1482004

欧洲维生素 K2 市场预测至 2030 年 - 区域分析 - 按产品、剂型、来源和应用

Europe Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application

出版日期: 2024年03月04日 | 出版商:

The Insight Partners | 英文 88 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲维生素K2市场预计将从2022年的5,327万美元成长到2030年的4.231亿美元。

成人和新生儿骨质疏鬆症骨变形病例的增加推动了欧洲维生素 K2 市场

骨质疏鬆症是影响成人和婴儿的一个日益常见的健康问题，这种疾病的特征是骨骼衰弱和脆弱。根据国际骨质疏鬆基金会2022年的数据，全球骨质疏鬆症每年导致超过890万例骨折，每3秒就有1例骨质疏鬆性骨折。医疗专业人士对骨质疏鬆症相关骨变形病例的激增感到担忧。根据 Research Gate 最近的研究，维生素 K2 的潜在优势包括支持骨骼健康并可能减少骨质疏鬆症的后果。

维生素 K2 是一种鲜为人知的维生素 K，对于维持健康的钙代谢和骨密度至关重要。它刺激蛋白质将钙从血液转移到骨骼中，以确保足够的矿化和强度。该营养素透过改善钙吸收来帮助避免与骨质疏鬆症相关的骨折和畸形。成人骨质疏鬆症病例通常是由荷尔蒙变化、与年龄相关的骨质流失或食物摄取不足引起的。维生素 K2 补充剂在提高成人骨矿物质密度和降低骨折风险方面已显示出良好的效果。此外，女性由于骨质疏鬆症发生率较高，成为骨保健品的主要目标族群。骨质疏鬆症相关问题的发生率不断增加仍然是功能性食品和补充剂（例如钙和维生素 D）的焦点，它们是支持骨骼健康的主要成分。钙是骨骼的主要矿物质成分，而维生素则有助于钙的吸收。然而，随着消费者越来越意识到维生素 K2 的好处，其在食品和补充剂中的供应正在增加。此外，有人提出，维生素 K2 有助于降低破骨细胞的活性（破骨细胞会导致骨骼退化），进一步保护骨骼完整性。

新生儿可能会罹患骨质疏鬆症，尤其是早产儿。由于骨骼不成熟且脆弱，他们更容易骨折。在这些婴儿的治疗方案中，维生素 K2 可改善骨骼生长并减少骨骼异常的可能性。补充维生素 K2 可加速他们的骨骼发育，维生素 K2 支持生命早期阶段的自然发生过程。因此，成人和新生儿骨质疏鬆相关骨骼异常发生率的不断增加迫切需要有效的预防措施和治疗方法。因此，补充维生素 K2 是一种潜在的补充疗法，有助于钙代谢、骨矿化和预防骨折。所有这些因素都在推动市场成长。

欧洲维生素 K2 市场概况

欧洲维生素 K2 市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。市场的成长归因于心血管疾病盛行率的增加以及成人和新生儿骨质疏鬆症骨变形病例的增加。然而，人们对维生素 K2 益处的认识有限，阻碍了市场的成长。德国和义大利等国家预计将成为该地区市场成长的最重要贡献者，法国、英国和西班牙等国家可能有维生素 K2 的成长机会。由于人们对美学外观意识的增强，非手术紧肤和非手术减脂等非侵入性美容治疗的激增，欧洲维生素 K2 市场预计将成长。此外，医疗器材产业的发展和美容诊所数量的增加可能会提供重要的成长机会。

欧洲维生素 K2 市场收入及 2030 年预测（百万美元）

欧洲维生素 K2 市场区隔

欧洲维生素 K2 市场按产品、剂型、来源、应用和国家细分。

根据产品，欧洲维生素 K2 市场分为 MK-4、MK-7 和组合药物。 2022 年，MK-7 细分市场将占据欧洲维生素 K2 市场的最大份额。

根据剂型，欧洲维生素 K2 市场分为胶囊和片剂、粉末和油。到 2022 年，粉末细分市场将占据欧洲维生素 K2 市场的最大份额。

根据来源，欧洲维生素 K2 市场分为天然维生素 K2 和合成维生素 K2。 2022 年，天然维生素 K2 在欧洲维生素 K2 市场中占有更大份额。

根据应用，欧洲维生素 K2 市场分为药品、营养保健品和食品等。 2022 年，药品领域占据欧洲维生素 K2 市场的最大份额。

根据国家/地区，欧洲维生素 K2 市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲维生素 K2 市场占据主导地位。

Anderson Global Group LLC、Balchem Corp、BASF SE、Glanbia Plc、International Flavors & Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG 和 Novozymes AS 是欧洲维生素 K2 市场上的一些领先公司。

Osteoporosis is an increasingly common health issue affecting adults and babies, a disorder marked by weakening and fragile bones. According to International Osteoporosis Foundation 2022, globally osteoporosis causes more than 8.9 million fractures every year resulting in osteoporotic fracture in every 3 seconds. Medical professionals are concerned about the surge in osteoporosis-related bone distortion cases. As per recent studies from Research Gate, the potential advantages of vitamin K2 include supporting bone health and possibly reducing the consequences of osteoporosis.

Vitamin K2 is a lesser-known vitamin K essential for maintaining healthy calcium metabolism and bone density. It stimulates proteins that transfer calcium from the bloodstream into the bones to ensure adequate mineralization and strength. The nutrient aid in avoiding osteoporosis-related bone fractures and deformities by improving calcium absorption. Adult osteoporosis cases frequently result from hormonal changes, age-related bone loss, or inadequate food intake. Vitamin K2 supplementation has demonstrated promising outcomes in enhancing bone mineral density and lowering fracture risk among adults. In addition, women are the main target for bone health products due to their higher incidence of osteoporosis. The increasing incidence of osteoporosis-related difficulties continues to be a key focus for functional foods and supplements such as calcium and vitamin D are the primary components supporting bone health. Calcium is the main mineral component of bones, while vitamin helps with calcium absorption. changes However, as consumers are becoming more aware of the benefits of vitamin K2, its availability in foods and supplements is rising. In addition, it has been proposed that vitamin K2 aids in reducing the activity of osteoclast cells, which are responsible for bone deterioration, further protecting bone integrity.

Newborns can develop osteoporosis, especially preterm babies. They are more prone to fractures since their bones are immature and weak. Vitamin K2 improves bone growth and lessens the likelihood of bone abnormalities in the therapy regimens for these infants. Their skeletal development is accelerated by vitamin K2 supplementation, which supports the naturally occurring processes during the early stages of life. Thus, the growing number of adult and neonatal incidences of osteoporosis-related bone abnormalities creates the urgent need for efficient preventative measures and treatment approaches. Hence, vitamin K2 supplementation acts as a potential supplementary therapy that helps with calcium metabolism, bone mineralization, and the prevention of fractures. All these factors are driving the market growth.

Europe Vitamin K2 Market Overview

The Europe vitamin K2 market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. Countries such as Germany and Italy are expected to be the most significant contributors to market growth in the region and countries such as France, the UK, and Spain are likely to have growth opportunities for vitamin K2. The European vitamin K2 market is expected to grow owing to the surge in non-invasive aesthetic treatments such as non-surgical skin tightening and non-surgical fat reductions due to increased awareness of aesthetic appearance. Furthermore, the medical devices industry developments and the rising numbers of aesthetic clinics may offer vital growth opportunities.

Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

Europe Vitamin K2 Market Segmentation

The Europe vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the Europe vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Europe vitamin K2 market in 2022.

Based on dosage forms, the Europe vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Europe vitamin K2 market in 2022.

Based on source, the Europe vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Europe vitamin K2 market in 2022.

Based on application, the Europe vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Europe vitamin K2 market in 2022.

Based on country, the Europe vitamin K2 market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe vitamin K2 market in 2022.

Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the Europe vitamin K2 market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Vitamin K2 Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of CVD
- 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
4.2 Market Restraints
- 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
4.3 Market Opportunities
- 4.3.1 Expansion of Distribution Channel
4.4 Future Trends
- 4.4.1 Regulatory Consideration and Standards
4.5 Impact Analysis:

5. Vitamin K2 Market - Europe Market Analysis

5.1 Europe Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

6.1 Overview
6.2 Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
6.3 MK-4
- 6.3.1 Overview
- 6.3.2 MK-4: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.4 MK-7
- 6.4.1 Overview
- 6.4.2 MK-7: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Combination Drugs
- 6.5.1 Overview
- 6.5.2 Combination Drugs: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

7.1 Overview
7.2 Europe Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
7.3 Capsules and Tablets
- 7.3.1 Overview
- 7.3.2 Capsules and Tablets: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Powder
- 7.4.1 Overview
- 7.4.2 Powder: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Oil
- 7.5.1 Overview
- 7.5.2 Oil: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

8.1 Overview
8.2 Europe Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
8.3 Natural
- 8.3.1 Overview
- 8.3.2 Natural: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Synthetic
- 8.4.1 Overview
- 8.4.2 Synthetic: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

9.1 Overview
9.2 Europe Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Pharmaceuticals
- 9.3.1 Overview
- 9.3.2 Pharmaceuticals: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Nutraceuticals and Food
- 9.4.1 Overview
- 9.4.2 Nutraceuticals and Food: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Vitamin K2 Market - Country Analysis

10.1.1 Europe Vitamin K2 Market by Country
- 10.1.1.1 Germany
  - 10.1.1.1.1 Overview
  - 10.1.1.1.2 Germany: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.1.3 Germany: Europe Vitamin K2 Market, by Product
  - 10.1.1.1.4 Germany: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.1.5 Germany: Europe Vitamin K2 Market, by Source
  - 10.1.1.1.6 Germany: Europe Vitamin K2 Market, by Application
- 10.1.1.2 UK
  - 10.1.1.2.1 Overview
  - 10.1.1.2.2 UK: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.2.3 UK: Europe Vitamin K2 Market, by Product
  - 10.1.1.2.4 UK: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.2.5 UK: Europe Vitamin K2 Market, by Source
  - 10.1.1.2.6 UK: Europe Vitamin K2 Market, by Application
- 10.1.1.3 France
  - 10.1.1.3.1 Overview
  - 10.1.1.3.2 France: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.3.3 France: Europe Vitamin K2 Market, by Product
  - 10.1.1.3.4 France: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.3.5 France: Europe Vitamin K2 Market, by Source
  - 10.1.1.3.6 France: Europe Vitamin K2 Market, by Application
- 10.1.1.4 Italy
  - 10.1.1.4.1 Overview
  - 10.1.1.4.2 Italy: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.4.3 Italy: Europe Vitamin K2 Market, by Product
  - 10.1.1.4.4 Italy: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.4.5 Italy: Europe Vitamin K2 Market, by Source
  - 10.1.1.4.6 Italy: Europe Vitamin K2 Market, by Application
- 10.1.1.5 Spain
  - 10.1.1.5.1 Overview
  - 10.1.1.5.2 Spain: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.5.3 Spain: Europe Vitamin K2 Market, by Product
  - 10.1.1.5.4 Spain: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.5.5 Spain: Europe Vitamin K2 Market, by Source
  - 10.1.1.5.6 Spain: Europe Vitamin K2 Market, by Application
- 10.1.1.6 Rest of Europe
  - 10.1.1.6.1 Overview
  - 10.1.1.6.2 Rest of Europe: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.6.3 Rest of Europe: Europe Vitamin K2 Market, by Product
  - 10.1.1.6.4 Rest of Europe: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.6.5 Rest of Europe: Europe Vitamin K2 Market, by Source
  - 10.1.1.6.6 Rest of Europe: Europe Vitamin K2 Market, by Application

11. Vitamin K2 Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in Vitamin K2 Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 International Flavors & Fragrances Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Balchem Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 BASF SE
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Lesaffre et Cie SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Koninklijke DSM NV
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Novozymes AS
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Glanbia Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Anderson Global Group LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Vitamin K2 Market Segmentation
Table 2. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 3. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 4. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 5. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 6. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 7. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 8. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 9. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 10. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 11. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 12. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - End-User
Table 13. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 14. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 15. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 16. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 17. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 18. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 19. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 20. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 21. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 22. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 23. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 24. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 25. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 26. Recent Organic Growth Strategies in Vitamin K2 Market
Table 27. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 28. Glossary of Terms, Europe Vitamin K2 Market

List Of Figures

Figure 1. Europe Vitamin K2 Market Segmentation, By Country
Figure 2. Europe Vitamin K2 Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. MK-4: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. MK-7: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Combination Drugs: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 10. Capsules and Tablets: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Powder: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Oil: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 14. Natural: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Synthetic: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Pharmaceuticals: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Nutraceuticals and Food: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Vitamin K2 Market, By Country, 2022 ($Mn)
Figure 21. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
Figure 22. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
Figure 23. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 24. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 28. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies in Vitamin K2 Market